Remove 2026 Remove Healthcare Provider Remove Pharma
article thumbnail

Connected customer data: a golden opportunity for pharma marketers

pharmaphorum

Approximately 30% of global data volume is generated by the healthcare industry and it will continue to expand with a compound annual growth rate predicted to reach 36% by 2025, according to research by RBC Capital Markets. Pharma is a highly regulated industry and that is often why it is slow to adopt new technologies,” says Kazuki.

article thumbnail

Why we need to support healthcare’s vital acceleration

pharmaphorum

Let me explain our four reasons for making healthcare a priority in greater detail: Firstly, healthcare’s historic acceleration means investments, both public and private, and revenues are likely to grow steadily. Overall, the industry is steadily becoming more consolidated and is likely to continue to do so.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Reaching Crucial Hispanic Patient Audiences

PM360

By 2026, the U.S. Roughly 62% prefer healthcare information resources in Spanish, while 67% say their cultural heritage influences their purchase decisions. One immediate benefit of inclusive marketing—helping bridge barriers with healthcare providers. Census estimates 69.7 million Hispanics will be in the U.S.,

article thumbnail

Making Sense of the Latest Changes to the Market Access Landscape

PM360

No one has ever described the pharma market access landscape as simple or easy to understand, and the passage of the Inflation Reduction Act (IRA) is not likely to change that. Most immediately, it will add confusion in the healthcare space,” explains Daniel Sontupe, Associate Partner, Managing Director, The Bloc Value Builders.

article thumbnail

U.S. market access landscape: A push for control is erasing the boundary between payers and providers in U.S. healthcare

Clarivate

Oak Street has 169 locations across 21 states and expects to nearly double its size to 300 centers by 2026. CVS’ bid for Oak Street is in keeping with nearly two decades of evolution toward becoming an integrated payer and provider. healthcare organizations Company Founded Type No. Key acquisitions by U.S.

article thumbnail

Specialty Treatments Require a New Approach to Affordability

PM360

GoodRx is the leading platform 2 with the highest unaided awareness and trust across patients, physicians, and pharmacists 3 that Americans—regardless of insurance status—use across many phases of their healthcare journey. United States Specialty Pharmaceuticals Market & Forecast 2020-2026,” BusinessWire, December 8, 2020.